Neoadjuvant chemotherapy in operable breast cancer

European Journal of Cancer and Clinical Oncology

Volumn 27, Issue 12, 1991, Pages 1668-1671

  Scholl, S M ^a   Asselain, B ^a   Palangie, T ^a   Dorval, T ^a   Jouve, M ^a   Garcia Giralt, E ^a   Vilcoq, J ^a   Durand, J C ^a   Pouillart, P ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADULT; ARTICLE; BREAST CANCER; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMAN; MIDDLE AGE; PROGNOSIS;

EID: 0026316516     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(91)90442-G     Document Type: Article

References (7)

1. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases
2. Effect of local or systemic treatment prior to primary tumor removal on inhibitions of a growth factor in serum following operation
3. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
4. Prognostic factors of breast cancer recurrence in the conservative management of early breast cancer: a 25-year follow-up
5. Evaluation of survival data and two new rank order statistics arising in its consideration
6. Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma
7. Conceptual and practical advances in the management of breast cancer